Cello World Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 6:48 pm

Quick Insight

Cello World Ltd, trading at ₹592 per share with a market cap of ₹13,075 Cr., shows a P/E ratio of 38.6 and an impressive ROE of 20.4% along with a robust ROCE of 23.7%. The company maintains a healthy OPM of 23% and a high net profit of ₹365 Cr. With promoters holding 75% of shares and FIIs, DIIs, and public holding 7.47%, 13.54%, and 3.97% respectively, it indicates strong investor confidence. Cello's solid financial position is underscored by reserves of ₹2,057 Cr. and negligible borrowings at ₹5 Cr., resulting in a comfortable ICR of 382.19x. This suggests a well-capitalized company with promising growth prospects.

Competitors of Cello World Ltd

All Competitor Stocks of Cello World Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:34 am

Below is a detailed analysis of the quarterly data for Cello World Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 589.00 Cr.. The value appears strong and on an upward trend. It has increased from 557.00 Cr. (Dec 2024) to 589.00 Cr., marking an increase of 32.00 Cr..
• For Expenses, as of Mar 2025, the value is 454.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 430.00 Cr. (Dec 2024) to 454.00 Cr., marking an increase of 24.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Dec 2024) to 135.00 Cr., marking an increase of 8.00 Cr..
• For OPM %, as of Mar 2025, the value is 23.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 23.00%.
• For Other Income, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Dec 2024) to 13.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Dec 2024) to 18.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Dec 2024) to 130.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Mar 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 26.00%.
• For Net Profit, as of Mar 2025, the value is 96.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Dec 2024) to 96.00 Cr., marking an increase of 4.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.99. The value appears strong and on an upward trend. It has increased from 3.91 (Dec 2024) to 3.99, marking an increase of 0.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 2:19 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:36 pm

Below is a detailed analysis of the balance sheet data for Cello World Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 110.00 Cr.. The value appears strong and on an upward trend. It has increased from 106.00 Cr. (Mar 2024) to 110.00 Cr., marking an increase of 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,043.00 Cr. (Mar 2024) to 2,057.00 Cr., marking an increase of 1,014.00 Cr..
• For Borrowings, as of Mar 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 371.00 Cr. (Mar 2024) to 5.00 Cr., marking a decrease of 366.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 467.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 450.00 Cr. (Mar 2024) to 467.00 Cr., marking an increase of 17.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,640.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,970.00 Cr. (Mar 2024) to 2,640.00 Cr., marking an increase of 670.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 616.00 Cr.. The value appears strong and on an upward trend. It has increased from 362.00 Cr. (Mar 2024) to 616.00 Cr., marking an increase of 254.00 Cr..
• For CWIP, as of Mar 2025, the value is 19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 180.00 Cr. (Mar 2024) to 19.00 Cr., marking a decrease of 161.00 Cr..
• For Investments, as of Mar 2025, the value is 600.00 Cr.. The value appears strong and on an upward trend. It has increased from 170.00 Cr. (Mar 2024) to 600.00 Cr., marking an increase of 430.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,406.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,258.00 Cr. (Mar 2024) to 1,406.00 Cr., marking an increase of 148.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,640.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,970.00 Cr. (Mar 2024) to 2,640.00 Cr., marking an increase of 670.00 Cr..

Notably, the Reserves (2,057.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Cello World Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 15.50. This value is within the healthy range. It has decreased from 15.60 (Mar 24) to 15.50, marking a decrease of 0.10.
• For Diluted EPS (Rs.), as of Mar 25, the value is 15.50. This value is within the healthy range. It has decreased from 15.60 (Mar 24) to 15.50, marking a decrease of 0.10.
• For Cash EPS (Rs.), as of Mar 25, the value is 19.33. This value is within the healthy range. It has decreased from 19.48 (Mar 24) to 19.33, marking a decrease of 0.15.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.12. It has increased from 64.55 (Mar 24) to 98.12, marking an increase of 33.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.12. It has increased from 64.55 (Mar 24) to 98.12, marking an increase of 33.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 96.72. It has increased from 94.25 (Mar 24) to 96.72, marking an increase of 2.47.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 25.13. This value is within the healthy range. It has decreased from 25.20 (Mar 24) to 25.13, marking a decrease of 0.07.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.32. This value is within the healthy range. It has decreased from 22.52 (Mar 24) to 22.32, marking a decrease of 0.20.
• For PBT / Share (Rs.), as of Mar 25, the value is 22.26. This value is within the healthy range. It has decreased from 22.40 (Mar 24) to 22.26, marking a decrease of 0.14.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 16.52. This value is within the healthy range. It has decreased from 16.81 (Mar 24) to 16.52, marking a decrease of 0.29.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has decreased from 15.60 (Mar 24) to 15.34, marking a decrease of 0.26.
• For PBDIT Margin (%), as of Mar 25, the value is 25.98. This value is within the healthy range. It has decreased from 26.73 (Mar 24) to 25.98, marking a decrease of 0.75.
• For PBIT Margin (%), as of Mar 25, the value is 23.07. This value exceeds the healthy maximum of 20. It has decreased from 23.89 (Mar 24) to 23.07, marking a decrease of 0.82.
• For PBT Margin (%), as of Mar 25, the value is 23.01. This value is within the healthy range. It has decreased from 23.77 (Mar 24) to 23.01, marking a decrease of 0.76.
• For Net Profit Margin (%), as of Mar 25, the value is 17.07. This value exceeds the healthy maximum of 10. It has decreased from 17.83 (Mar 24) to 17.07, marking a decrease of 0.76.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.85. This value is within the healthy range. It has decreased from 16.55 (Mar 24) to 15.85, marking a decrease of 0.70.
• For Return on Networth / Equity (%), as of Mar 25, the value is 15.63. This value is within the healthy range. It has decreased from 28.80 (Mar 24) to 15.63, marking a decrease of 13.17.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.26. This value is within the healthy range. It has decreased from 33.70 (Mar 24) to 20.26, marking a decrease of 13.44.
• For Return On Assets (%), as of Mar 25, the value is 12.82. This value is within the healthy range. It has decreased from 16.79 (Mar 24) to 12.82, marking a decrease of 3.97.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.00, marking a decrease of 0.31.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.92. It has decreased from 1.14 (Mar 24) to 0.92, marking a decrease of 0.22.
• For Current Ratio (X), as of Mar 25, the value is 9.31. This value exceeds the healthy maximum of 3. It has increased from 2.39 (Mar 24) to 9.31, marking an increase of 6.92.
• For Quick Ratio (X), as of Mar 25, the value is 6.79. This value exceeds the healthy maximum of 2. It has increased from 1.56 (Mar 24) to 6.79, marking an increase of 5.23.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 4. It has decreased from 1.53 (Mar 24) to 1.40, marking a decrease of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 382.19. This value is within the healthy range. It has increased from 209.44 (Mar 24) to 382.19, marking an increase of 172.75.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 252.25. This value is within the healthy range. It has increased from 140.68 (Mar 24) to 252.25, marking an increase of 111.57.
• For Enterprise Value (Cr.), as of Mar 25, the value is 12,217.61. It has decreased from 16,958.80 (Mar 24) to 12,217.61, marking a decrease of 4,741.19.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.72. This value exceeds the healthy maximum of 3. It has decreased from 8.48 (Mar 24) to 5.72, marking a decrease of 2.76.
• For EV / EBITDA (X), as of Mar 25, the value is 22.01. This value exceeds the healthy maximum of 15. It has decreased from 31.71 (Mar 24) to 22.01, marking a decrease of 9.70.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.65. This value exceeds the healthy maximum of 3. It has decreased from 8.22 (Mar 24) to 5.65, marking a decrease of 2.57.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 5.57. This value exceeds the healthy maximum of 3. It has decreased from 14.31 (Mar 24) to 5.57, marking a decrease of 8.74.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.65. This value exceeds the healthy maximum of 3. It has decreased from 8.22 (Mar 24) to 5.65, marking a decrease of 2.57.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness